SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Molecular Insight Pharmaceuticals, Inc. Presents Positive Phase 1 Prostate Cancer Data at the Annual Congress of the European Association of Nuclear Medicine